Type 1 Diabetes Mellitus
5 competing products in clinical development for Type 1 Diabetes Mellitus.
Pipeline by Phase
Pre-clinical1
Phase 11
Phase 21
Phase 2/31
Phase 31
All Products (5)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| ipragliflozin + Placebo | Astellas Pharma | Phase 3 | Completed | 40 |
| Teplizumab + Placebo | Eli Lilly | Phase 2/3 | Completed | 38 |
| Placebo + ASP1941 | Astellas Pharma | Phase 2 | Completed | 35 |
| Insulin Lispro | Eli Lilly | Pre-clinical | Completed | 26 |
| teplizumab or placebo | Eli Lilly | Phase 1 | Terminated | 21 |